Stock HLN HALEON PLC
Add to a list
To use this feature you must be a member
Log inSign up

Governance Haleon plc

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
 13:03:15 09/09/2024 BST 		5-day change 1st Jan Change
392.45 GBX +0.71% Intraday chart for Haleon plc +2.51% +21.84%
09-04 Perrigo Company plc Appoints Charles Atkinson, as Executive Vice President, General Counsel and Secretary CI
09-03 Haleon Seeks M&A Opportunities CI

Executive Committee: Haleon plc

Manager
Positions heldSince
Brian McNamara

Brian McNamara

57 year

Chief Executive Officer 21/07/2021
Sonya Ghobrial

Sonya Ghobrial

-

Investor Relations Contact -
Amanda Mellor

Amanda Mellor

60 year

Corporate Secretary 22/05/2022
Bjarne Tellmann

Bjarne Tellmann

57 year

General Counsel 15/12/2021
Tobias Hestler

Tobias Hestler

52 year

Director of Finance/CFO 30/11/2021
Tamara Rogers

Tamara Rogers

-

Sales & Marketing 15/12/2021
Franck Riot

Franck Riot

-

Chief Tech/Sci/R&D Officer 15/12/2021
Mairéad Nayager

Mairéad Nayager

-

Human Resources Officer 28/02/2022

Composition of the Board of Directors: Haleon plc

Director
CommitteesSince
David Lewis

David Lewis

59 year

Governance Committee Chair 22/05/2022
Nominating Committee Chair 22/05/2022
Tracy Clarke

Tracy Clarke

57 year

Audit Committee 17/07/2022
Finance Committee
Compensation Committee Chair
Compensation Committee 31/12/2020
Nominating Committee 17/07/2022
Governance Committee 17/07/2022
Deirdre Mahlan

Deirdre Mahlan

61 year

Audit Committee 14/09/2021
Compensation Committee 17/07/2022
Governance Committee 17/07/2022
Nominating Committee 17/07/2022
Audit Committee Chair 17/07/2022
Vindi Banga

Vindi Banga

69 year

Audit Committee 17/07/2022
Compensation Committee 17/07/2022
Governance Committee 17/07/2022
Nominating Committee 17/07/2022
Alan Stewart

Alan Stewart

64 year

Compensation Committee 31/08/2022
Nominating Committee 31/08/2022
Audit Committee Chair 31/08/2022
Dame Cox

Dame Cox

64 year

Audit Committee 17/07/2022
Compensation Committee 17/07/2022
Nancy Avila

Nancy Avila

58 year

Director/Board Member 31/08/2024
Independent Dir/Board Member 31/08/2024
Tobias Hestler

Tobias Hestler

52 year

Director/Board Member 22/05/2022
Marie-Anne Aymerich

Marie-Anne Aymerich

- year

Director/Board Member 17/07/2022
Independent Dir/Board Member 17/07/2022
Asmita Dubey

Asmita Dubey

- year

Director/Board Member 17/07/2022
Independent Dir/Board Member 17/07/2022
Bryan Supran

Bryan Supran

- year

Director/Board Member 17/07/2022
David Denton

David Denton

59 year

Director/Board Member 28/02/2023
Brian McNamara

Brian McNamara

57 year

Director/Board Member 22/05/2022

Latest Appointments: Haleon plc

Perrigo Company plc Appoints Charles Atkinson, as Executive Vice President, General Counsel and Secretary CI
Tate & Lyle picks former De Beers CFO to be its new CFO AN
Tate & Lyle's New CFO to Join mid-September MT
Haleon adds former Tesco and M&S CFO Alan Stewart to board AN
Haleon plc Announces Board and Committees Appointments CI
Haleon plc Announces Directorate Change CI
Haleon: a new CFO at the end of October CF
More news

Former Officers and Directors: Haleon plc

Insider
Positions heldSinceUntil
Bart Derde
Bart Derde
Corporate Officer/Principal 31/12/2021 31/12/2023
Amy Landucci
Amy Landucci
Chief Tech/Sci/R&D Officer 15/12/2021 31/12/2023
Jooyong Lee
Jooyong Lee
Corporate Officer/Principal 15/12/2021 30/12/2023
Teri Lyng
Teri Lyng
Corporate Officer/Principal 15/12/2021 30/12/2023
Bernadette Behnke
Bernadette Behnke
Private Equity Investor 30/09/2022 30/09/2023
John Young
John Young
Director/Board Member - 27/02/2023
Chirag Nakum
Chirag Nakum
Public Communications Contact - -
Nidaa Lone
Nidaa Lone
Public Communications Contact - -

Age distribution of managers

Parity Men Women

Male 14
Female 13

Of which Executive Committee

Male 4
Female 4

Of which Directors

Male 7
Female 6
ESG Refinitiv
B

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Company Profile

Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Employees
25,408
Sector
Pharmaceuticals
Calendar
31/10/2024 - Q3 2024 Sales and Revenue Release - Trading Statement
Related indices
STOXX Europe 600 Index (EUR) , FTSE 100
More about the company
  1. Stock Market
  2. Equities
  3. HLN Stock
  4. Company Haleon plc
  5. Governance
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition